Surface expression of heterogeneous nuclear RNA binding protein M4 on Kupffer cell relates to its function as a carcinoembryonic antigen receptor.
Elevated concentrations of carcinoembryonic antigen (CEA) in the blood are associated with the development of hepatic metastases from colorectal cancers. Clearance of circulating CEA occurs through endocytosis by liver macrophages, Kupffer cells. Previously we identified heterogeneous nuclear ribonucleoproteins M4 (hnRNP M4) as a receptor (CEAR) for CEA. HnRNP M4 has two isoform proteins (p80, p76), the full-length hnRNP M4 (CEARL) and a truncated form (CEARS) with a deletion of 39 amino acids between RNA binding domains 1 and 2, generated by alternative splicing. The present study was undertaken to clarify any isoform-specific differences in terms of their function as CEA receptor and localization. We develop anti-CEAR isoform-specific antibodies and show that both CEAR splicing isoforms are expressed on the surface of Kupffer cells and can function as CEA receptor. Alternatively, in P388D1 macrophages CEARS protein has nuclear and CEARL has cytoplasmic localization. In MIP101 colon cancer and HeLa cells the CEARS protein is localized to the nucleus and CEARL to the cytoplasm. These findings imply that different functions are assigned to CEAR isoforms depending on the cell type. The search of 39 amino acids deleted region against the Prosite data base revealed the presence of N-myristylation signal PGGPGMITIP that may be involved in protein targeting to the plasma membrane. Overall, this report demonstrates that the cellular distribution, level of expression, and relative amount of CEARL and CEARS isoforms determine specificity for CEA binding and the expression of alternative spliced forms of CEAR is regulated in a tissue-specific manner.
Bajenova
Olga
O
Department of Surgery, Boston University School of Medicine, 801 Albany Street, Boston, MA 02118, USA. baj@bu.edu
Stolper
Eugenia
E
Gapon
Svetlana
S
Sundina
Natalia
N
Zimmer
Regis
R
Thomas
Peter
P
D017398:Alternative Splicing / Q000276:immunology; D000595:Amino Acid Sequence / Q000502:physiology; D000818:Animals; D000906:Antibodies; D001665:Binding Sites / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000378:metabolism*; D002277:Carcinoma / Q000556:secondary; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism*; D002467:Cell Nucleus / Q000276:immunology / Q000378:metabolism; D002478:Cells, Cultured; D015179:Colorectal Neoplasms / Q000473:pathology; D003593:Cytoplasm / Q000276:immunology / Q000378:metabolism; D006367:HeLa Cells; D034761:Heterogeneous-Nuclear Ribonucleoprotein Group M / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007728:Kupffer Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D008113:Liver Neoplasms / Q000556:secondary; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D008297:Male; D008970:Molecular Weight; D020033:Protein Isoforms / Q000276:immunology / Q000378:metabolism; D017434:Protein Structure, Tertiary / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D034781:Receptors, N-Acetylglucosamine / Q000276:immunology / Q000378:metabolism*
D000906:Antibodies; D002272:Carcinoembryonic Antigen; C440104:HNRNPM protein, human; D034761:Heterogeneous-Nuclear Ribonucleoprotein Group M; D020033:Protein Isoforms; D034781:Receptors, N-Acetylglucosamine